Autoantibodies to the GM2-1 Islet Ganglioside and to GAD-65 at Type 1 Diabetes Onset
- 31 December 1997
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 10 (6) , 585-588
- https://doi.org/10.1006/jaut.1997.0166
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Pathogenesis of Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1994
- Islet cell autoantigens in insulin-dependent diabetes.Journal of Clinical Investigation, 1993
- Rat Pancreatic Ganglioside Expression: Differences between a Model of Autoimmune Islet B Cell Destruction and a Normal StrainClinical Immunology and Immunopathology, 1993
- Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes.Journal of Clinical Investigation, 1993
- Distinct cytoplasmic islet cell antibodies with different risks for Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1992
- Prognostically Significant Heterogeneity of Cytoplasmic Islet Cell Antibodies in Relatives of Patients with Type I DiabetesDiabetes, 1992
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- “Cytoplasmic” Islet Cell Antibodies: Evidence That the Target Antigen Is a SialoglycoconjugateDiabetes, 1985
- Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin TreatmentScience, 1983
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIESThe Lancet, 1974